Dr Michael Stein has been chief executive of Valo Therapeutics, an immuno-oncology company, since March 2019. Prior to that, he was the founding chief executive of OxStem (an award-winning biotechnology spin-out from the University of Oxford), founding chief executive of Doctor Care Anywhere (a UK-based telemedicine platform acquired by Synergix in 2015), and a co-founder and chief executive of the Map of Medicine (a set of clinical algorithms that represented the patient healthcare journey from suspected diagnosis to treatment across all healthcare settings) with University College London. Dr Stein is a business leader and strategic advisor with C-suite experience in healthcare. He graduated as a medical doctor and biochemist from the University of Cape Town with a Doctorate in Physiological Sciences from the University of Oxford which he attended as a Rhodes Scholar.
